Renascience Inc. (TYO:4889)

Renascience Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	3,204	3,402	1,799	2,026	2,212	2,386
Cash & Short-Term Investments	3,204	3,402	1,799	2,026	2,212	2,386
Cash Growth	91.40%	89.11%	-11.20%	-8.41%	-7.29%	132.78%
Accounts Receivable	-	-	-	4	-	-
Other Receivables	-	10	17	-	-	-
Receivables	-	10	17	4	-	-
Prepaid Expenses	49	52	42	29	29	31
Other Current Assets	40	39	13	27	26	11
Total Current Assets	3,293	3,503	1,871	2,086	2,267	2,428
Property, Plant & Equipment	-	-	-	-	4	3
Long-Term Investments	-	-	-	2	2	6
Other Long-Term Assets	-	-	-	-	1	1
Total Assets	3,293	3,503	1,871	2,088	2,274	2,438

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	1	-	1	-	-	-
Accrued Expenses	3	20	1	2	2	2
Current Income Taxes Payable	47	154	144	123	97	35
Other Current Liabilities	2	6	5	1	1	-
Total Current Liabilities	53	180	151	126	100	37
Long-Term Debt	-	-	-	356	309	199
Other Long-Term Liabilities	-	1	-	-	-	2
Total Liabilities	53	181	151	482	409	238

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	1,982	1,982	1,036	1,036	1,036	1,036
Additional Paid-In Capital	2,464	2,464	1,518	1,518	1,518	1,518
Retained Earnings	-1,218	-1,136	-835	-948	-690	-354
Comprehensive Income & Other	12	12	1	-	1	-
Shareholders' Equity	3,240	3,322	1,720	1,606	1,865	2,200
Total Liabilities & Equity	3,293	3,503	1,871	2,088	2,274	2,438

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	-	-	-	356	309	199
Net Cash (Debt)	3,204	3,402	1,799	1,670	1,903	2,187
Net Cash Growth	91.40%	89.11%	7.72%	-12.24%	-12.99%	297.64%
Net Cash Per Share	243.75	264.17	141.52	131.38	149.70	192.03
Filing Date Shares Outstanding	13.78	13.33	12.71	12.71	12.71	12.69
Total Common Shares Outstanding	13.78	13.33	12.71	12.71	12.71	12.69
Working Capital	3,240	3,323	1,720	1,960	2,167	2,391
Book Value Per Share	235.18	249.27	135.31	126.34	146.72	173.40
Tangible Book Value	3,240	3,322	1,720	1,606	1,865	2,200
Tangible Book Value Per Share	235.18	249.27	135.31	126.34	146.72	173.40

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 25, 2026

Data Sources Report a data error